Meddev Distribution LLC

MedDev is a healthcare technology company specializing in regenerative medicine and advanced wound care solutions. The company distributes biologic skin substitutes based on amniotic membrane technology, designed to accelerate healing in chronic wounds, burn wounds, ophthalmic applications, and surgical procedures. Their product portfolio includes multiple branded skin substitute lines (XCell, XCellerate, Royal Wound, Precise, Royal Bio, BioLab, DermMax, and EnColl). Beyond product distribution, MedDev provides integrated practice optimization services including revenue cycle management, workflow efficiency enhancement, administrative burden reduction, and scheduling optimization. The company serves healthcare providers, clinical partners, and distributors across the United States. MedDev's regenerative solutions leverage amniotic membrane grafts containing growth factors and cytokines to promote cell proliferation, tissue regeneration, inflammatory modulation, and minimal immune response. The company emphasizes compliance-first operations, clinical research backing, and hands-on provider support. Their business model combines premium biologic products with comprehensive practice management services to optimize both patient outcomes and provider operations.